Medscape Eye (@MedscapeEye) header
Medscape Eye (@MedscapeEye) profile picture

Medscape Ophthalmology provides you with breaking medical news; reference on drugs, diseases, and procedures; and free CME.

Joined January 2010
Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)Photo by Medscape Eye (@MedscapeEye)
Standard exams don't always capture the true day-to-day of living with generalized myasthenia gravis. Our panel breaks down why early recognition and disease management are critical for gMG care. Watch the expert breakdown here ➡️ mdsc.pe/3VMK9ui #Neurology #CME
1
52
How can you better identify the invisible symptoms and daily burden of generalized myasthenia gravis? Hear key insights from neurology experts and a patient advocate on shifting care toward personalized treatment goals. Catch the replay ➡️ mdsc.pe/4hLHpGf #MedEd #CME
1
57
Why do patients with generalized myasthenia gravis often struggle despite "looking fine" to others? Dr. Gable, Dr. Barnett-Tapia, and patient Ms. Tao Nguyen discuss the hidden burden and emotional weight of gMG. Watch the full discussion ➡️ mdsc.pe/4i2RSfb #MedEd #CME
37
The American Academy of Ophthalmology conference is October 9–12, 2026. Impressed with its thought leaders? Explore our curriculum, where women in ophthalmology discuss practical approaches to advancing retina care and improving patient outcomes. ▶️ mdsc.pe/4y8UP57
48
Starting in 1 HOUR ➡️ mdsc.pe/4hElvU5 Explore the daily realities and optimal treatment goals in generalized myasthenia gravis. Join leading experts and a patient advocate today. 📅 Today ⏰ 12:00pm ET #MyastheniaGravis #Neurology #CME
36
LIVE TOMORROW ➡️ mdsc.pe/4hElvU5 Gain expert insights on gMG disease burden and patient experience. Earn free 0.25 CME credits. 📅 October 6th ⏰ 12:00pm ET #Neurology #CME
57
Want to stay ahead of transformative science in generalized myasthenia gravis? Join experts to explore gMG symptom burden, treatment limits, and emerging therapies. Earn free 0.25 CME! 📅 October 6th ⏰ 12:00pm ET 🔗 mdsc.pe/4hElvU5 #Neurology #CME
53
SAVE THE DATE 🗓️ Join expert faculty and a patient advocate to examine the daily realities, burden, and optimal treatment goals for generalized myasthenia gravis. 📅 October 6th ⏰ 12:00pm ET 🔗 mdsc.pe/4hElvU5 #MyastheniaGravis #Neurology #CME
83
Advance your understanding of next-generation anti-VEGF therapies through expert-led discussions and the latest clinical evidence. Explore approaches that can support more effective management of retinal diseases. ▶️ mdsc.pe/3Qu0fWT
37
Women in Ophthalmology takes place August 20–23, 2026. Impressed with the thought leaders at this conference? Explore our curriculum, where women in ophthalmology discuss practical approaches to advancing retina care and improving patient outcomes. ▶️ mdsc.pe/4y8UP57
1
79
Explore our new curriculum as experts share insights on advancing clinical excellence in comprehensive eye care, highlighting current evidence, evolving treatment approaches, and strategies to improve patient outcomes. ▶️ mdsc.pe/4y8UP57
83
Explore new horizons in uveitic macular edema. Gain practical insights to elevate diagnosis and management, refine clinical decision-making, and improve patient outcomes in real-world care. ▶️ mdsc.pe/3Qu0fWT
29
More baby boomers see ophthalmologists, offsetting reimbursement declines but pushing overworked practioners hard. wb.md/2hwCkDf
Alternative to Corneal Transplant for Keratoconus Promising wb.md/2dJaQFs
Ocular Findings Prevalent With Congenital Zika wb.md/2eIh0I3
Mediterranean Diet May Cut AMD Risk by More Than a Third wb.md/2emn9Km
The Tracks of Our Tears: Why We Cry wb.md/2etwobi
2
1
Veterans Affairs Tracks 10-Year Cataract Surgery Results wb.md/2eBPMGP
1
1
FDA Clears Ranibizumab Injection in a Prefilled Syringe wb.md/2eEBi8d
Changing Ranibizumab Treatment Regimens in Neovascular AMD wb.md/2ekHUsR
2
1